ClinicalTrials.Veeva

Menu

Hip Arthroplasty with SL Cementless

L

Limacorporate

Status

Completed

Conditions

Hip Replacement

Treatments

Procedure: Hip arthroplasty with SL Cementless

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The study aims to evaluate the clinical, radiographical and patient-reported outcomes measurements up 3 years FU and to assess the survivorship of SL Cementless Stem after partial or total hip arthroplasty.

Enrollment

60 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

All patients that underwent to partial or total hip arthroplasty and implanted with SL cementless stem between Jan 2010 and Jan 2020 at Nemocnice Kyjov Hospital (CZ) in accordance with the indication for use of the product and site standard of practice.

Additional Inclusion criteria:

  • Availability of patients' immediate post-operative radiograph (baseline) and of a number of follow-up x-rays that the Principal Investigator deems sufficient for an effective radiographic implant evaluation and stability assessment;
  • Patient is willing and able to complete additional follow-up evaluations if needed after signing ICF.

Exclusion criteria

  • Age < 18 years;
  • Female patients who are pregnant, nursing, or planning a pregnancy

Trial design

60 participants in 1 patient group

SL Cementless
Description:
Since the trial is not comparative, the only arm implies the use of the investigational device (SL cementless femoral stem)
Treatment:
Procedure: Hip arthroplasty with SL Cementless

Trial contacts and locations

1

Loading...

Central trial contact

Gaia Pacassoni; Federica Azzimonti

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems